2019
DOI: 10.1016/j.humpath.2018.10.021
|View full text |Cite
|
Sign up to set email alerts
|

Microglandular adenosis is an advanced precursor breast lesion with evidence of molecular progression to matrix-producing metaplastic carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(12 citation statements)
references
References 32 publications
0
12
0
Order By: Relevance
“…Schwartz et al suggested a plausible role of ZNF862 in matrix-producing metaplastic carcinoma. 28 Peng et al reported ZNF862 associated with IgE-mediated type-I hypersensitivity in children. 29 The WES-identified heterozygous variant (p.A938T) in our study located close to and upstream of the Dimer_Tnp_hAT (hAT family C-terminal dimerization region) domain of ZNF862 protein (Figure 1D).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Schwartz et al suggested a plausible role of ZNF862 in matrix-producing metaplastic carcinoma. 28 Peng et al reported ZNF862 associated with IgE-mediated type-I hypersensitivity in children. 29 The WES-identified heterozygous variant (p.A938T) in our study located close to and upstream of the Dimer_Tnp_hAT (hAT family C-terminal dimerization region) domain of ZNF862 protein (Figure 1D).…”
Section: Resultsmentioning
confidence: 99%
“…ZNF862 is expressed ubiquitously across tissues ( Fagerberg et al, 2014 ), it may play various roles under different physiological condition. Schwartz et al, 2019 , suggested a plausible role of ZNF862 in matrix-producing metaplastic carcinoma. Peng et al, 2018 , reported ZNF862 associated with IgE-mediated type-I hypersensitivity in children.…”
Section: Resultsmentioning
confidence: 99%
“…The presence of TP53 mutation thus may indicate a risk of progression or presence of unsampled or undiagnosed associated invasive carcinoma. A case study by Schwartz et al 6 showed presence of stop-gain TP53 R213X mutation in MGA and associated carcinoma by sequencing, but p53 immunohistochemical staining was negative. The abovementioned mutation may alter/truncate TP53 protein, and thus is only reliably detected by sequencing.…”
Section: Molecular Featuresmentioning
confidence: 99%
“…Recent next-generation sequencing studies showed that MGA is clonally related to atypical MGA and associated basal-like or triple-negative (estrogen receptor [ER], progesterone receptor [PR], and HER2/neu [HER2] negative) breast carcinoma (TNBC); therefore, MGA is currently considered to be a nonobligate precursor of TNBC. 5,6 CLINICAL FEATURES Microglandular adenosis is a very rare breast lesion and is present in less than 0.1% of breast biopsies. To date MGA has been reported only in female patients.…”
mentioning
confidence: 99%
“…In some occasions, MPC has been associated with microglandular adenosis [6]. Schwartz et al have recently reported a case of microglandular adenosis with evidence of molecular progression to MPC [7].…”
Section: Discussionmentioning
confidence: 99%